https://www.selleckchem.com/pr....oducts/hydroxychloro
.6) and 28.4 months (95% CI 20.7-36., respectively. Eleven patients were alive and disease-free (69%). Disease recurrence occurred in five patients (31%). One patient died 30 months after CRS plus HIPEC due to distant brain metastasis. Univariate analysis of parameters related to DFS showed that advanced stage IV disease (p = 0.01), suboptimal CC-1 cytoreduction completeness (p = 0.01) and 11 high PCI score (p = 0.03) were independent factors associated with statistically significant poor DFS. CRS plus HIPEC is
Like
Comment
Share
